AU2001227084A1 - N-arylhydrazide compounds and use thereof as drugs - Google Patents
N-arylhydrazide compounds and use thereof as drugsInfo
- Publication number
- AU2001227084A1 AU2001227084A1 AU2001227084A AU2708401A AU2001227084A1 AU 2001227084 A1 AU2001227084 A1 AU 2001227084A1 AU 2001227084 A AU2001227084 A AU 2001227084A AU 2708401 A AU2708401 A AU 2708401A AU 2001227084 A1 AU2001227084 A1 AU 2001227084A1
- Authority
- AU
- Australia
- Prior art keywords
- arylhydrazide
- drugs
- compounds
- arylhydrazide compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000016157 | 2000-01-25 | ||
| JP2000-16157 | 2000-01-25 | ||
| JP2000264744 | 2000-09-01 | ||
| JP2000-264744 | 2000-09-01 | ||
| PCT/JP2001/000393 WO2001055093A1 (en) | 2000-01-25 | 2001-01-22 | N-arylhydrazide compounds and use thereof as drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001227084A1 true AU2001227084A1 (en) | 2001-08-07 |
Family
ID=26584120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001227084A Abandoned AU2001227084A1 (en) | 2000-01-25 | 2001-01-22 | N-arylhydrazide compounds and use thereof as drugs |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001227084A1 (en) |
| WO (1) | WO2001055093A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04005027A (en) * | 2001-11-28 | 2004-08-11 | Btg Int Ltd | Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds. |
| AU2008215948A1 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperazine derivatives for treatment of AD and related conditions |
| US9006283B2 (en) | 2007-07-12 | 2015-04-14 | Acumen Pharmaceuticals, Inc. | Methods of modifying amyloid β oligomers using non-peptidic compounds |
| US8962677B2 (en) | 2007-07-12 | 2015-02-24 | Acumen Pharmaceuticals, Inc. | Methods of restoring cognitive ability using non-peptidic compounds |
| US9217024B2 (en) | 2007-12-18 | 2015-12-22 | Acumen Pharmaceuticals, Inc. | ADDL receptor polypeptides, polynucleotides and host cells for recombinant production |
| MX2011008362A (en) | 2009-02-13 | 2011-08-24 | Shionogi & Co | Novel triazine derivative and pharmaceutical composition containing same. |
| US9144557B2 (en) * | 2009-10-13 | 2015-09-29 | Ligand Pharmaceuticals Inc. | Hematopoietic growth factor mimetic small molecule compounds and their uses |
| RU2565073C2 (en) | 2010-08-10 | 2015-10-20 | Сионоги Энд Ко., Лтд. | Triazine derivative and pharmaceutical composition including it, possessing analgesic activity |
| JP6075621B2 (en) | 2010-08-10 | 2017-02-08 | 塩野義製薬株式会社 | Novel heterocyclic derivatives and pharmaceutical compositions containing them |
| US9550763B2 (en) | 2012-02-09 | 2017-01-24 | Shionogi & Co., Ltd. | Heterocyclic ring and carbocyclic derivative |
| TWI637949B (en) | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | Aminotriazine derivative and pharmaceutical composition comprising the same |
| WO2015084749A1 (en) * | 2013-12-02 | 2015-06-11 | The Trustees Of Columbia University In The City Of New York | Modulating ferroptosis and treating excitotoxic disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58124767A (en) * | 1982-01-21 | 1983-07-25 | Mitsui Toatsu Chem Inc | Sulfamoylbenzoic acid derivatives |
| CA2125251C (en) * | 1993-06-07 | 2005-04-26 | Yoshiyuki Inada | A pharmaceutical composition for angiotensin ii-mediated diseases |
-
2001
- 2001-01-22 WO PCT/JP2001/000393 patent/WO2001055093A1/en not_active Ceased
- 2001-01-22 AU AU2001227084A patent/AU2001227084A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001055093A1 (en) | 2001-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001277741A1 (en) | 2-aminopyridine compounds and use thereof as drugs | |
| AU2001264313A1 (en) | Pyrazolopyridine compounds and use thereof as drugs | |
| AU2001277754A1 (en) | Proline derivatives and use thereof as drugs | |
| AU763356C (en) | Fused-ring compounds and use thereof as drugs | |
| AU2001256184A1 (en) | 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases | |
| AU2001280188A1 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
| AU2001269508A1 (en) | Drugs or cosmetics | |
| AU2002219135A1 (en) | Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors | |
| AU2001290239A1 (en) | Medicinal composition | |
| AU2002218502A1 (en) | Lactam compounds and medicinal use thereof | |
| AU2001227084A1 (en) | N-arylhydrazide compounds and use thereof as drugs | |
| AU2002221099A1 (en) | Combination drugs | |
| AU2001232244A1 (en) | Drug comprising combination | |
| AU2000231564A1 (en) | Phosphororganic compounds and the use thereof | |
| AU1053501A (en) | Polyazanaphthalene compound and medicinal use thereof | |
| AU2001260236A1 (en) | Restricted use syringe | |
| AU4085201A (en) | Pharmaceutical composition | |
| AU2001274535A1 (en) | Hydroxyformamidine derivatives and medicines containing the same | |
| AU4432001A (en) | Trityl-type compounds and their use | |
| AU2001282527A1 (en) | Antiparkinsonism drugs | |
| AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
| AUPR548601A0 (en) | Pyrazolopyrazinecompound and pharmaceutical use thereof | |
| AU2002308105A1 (en) | Benzoaxathiepin derivatives and their use as medicines | |
| AU2001262928A1 (en) | Pharmaceutical compositions and their use | |
| AU3586401A (en) | Pharmaceutical composition |